The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study

This study has been completed.
Information provided by (Responsible Party):
Olympus Biotech Corporation Identifier:
First received: October 7, 2010
Last updated: April 22, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)